Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • State News

    State News - Page 3

    Lupin wins award for Operational Excellence in manufacturing at India Pharma Awards 2019

    Lupin wins award for Operational Excellence in manufacturing at India Pharma Awards 2019

    Medical Dialogues Bureau4 Dec 2019 1:36 PM IST
    Mumbai: Pharma major Lupin Limited won the prestigious award for 'Operational Excellence in Manufacturing' at the India Pharma Awards 2019.The jury...
    Yes Bank approaches NCLT against Jaypee Healthcare to start insolvency process

    Yes Bank approaches NCLT against Jaypee Healthcare to start insolvency process

    Medical Dialogues Bureau4 Dec 2019 1:35 PM IST
    New Delhi: Yes Bank has approached the National Company Law Tribunal (NCLT), Allahabad to initiate insolvency proceedings against Jaypee Healthcare,...
    UP Govt orders pull back of substandard Atorvastatin medicine from govt hospitals

    UP Govt orders pull back of substandard Atorvastatin medicine from govt hospitals

    Farhat Nasim28 Nov 2019 2:14 PM IST
    The state government, hence, issued an order on November 19 to recall the entire batch of the medicine (Atorvastatin) that was supplied to more than ...
    Pharmacist arrested for selling Tydol Tablets in bulk sans prescription

    Pharmacist arrested for selling Tydol Tablets in bulk sans prescription

    Farhat Nasim23 Nov 2019 3:21 PM IST
    During the investigation, it was revealed that the two deceased had an overdose of the drug (Tydol tablets) that they had taken for pleasure which led...
    Chinese strategy: Dr Reddys outsources part manufacturing to local parties

    Chinese strategy: Dr Reddy's outsources part manufacturing to local parties

    Medical Dialogues Bureau22 Nov 2019 12:50 PM IST
    Hyderabad: Betting big on the Chinese market, Dr Reddy's Laboratories which has plans to launch over 70 products in the East Asian country has started...
    Cabinet nod to extension of pharmaceuticals purchase policy for pharma PSUs

    Cabinet nod to extension of pharmaceuticals purchase policy for pharma PSUs

    Medical Dialogues Bureau22 Nov 2019 12:28 PM IST
    New Delhi: The Union Cabinet on Wednesday approved the extension of Pharmaceuticals Purchase Policy (PPP) for pharmaceutical Central Public Sector...
    Pharmacists to protest at Jantar Mantar against amendment of Schedule K of Drugs and Cosmetics Act

    Pharmacists to protest at Jantar Mantar against amendment of Schedule K of Drugs and Cosmetics Act

    Farhat Nasim18 Nov 2019 2:55 PM IST
    New Delhi: The Indian Pharmacist Association (IPA) has decided to conduct a protest on November 29 at Jantar Mantar against the recent draft to amend...
    Government approves 4 medical device parks to cut import bill, production cost

    Government approves 4 medical device parks to cut import bill, production cost

    Farhat Nasim12 Nov 2019 9:30 AM IST
    The four medical device parks will provide the necessary infrastructure, where companies can easily plug and play. This will not only cut import bill...
    Wockhardt Q2 net loss widens to Rs 94 cr

    Wockhardt Q2 net loss widens to Rs 94 cr

    Medical Dialogues Bureau11 Nov 2019 1:11 PM IST
    New Delhi: Pharma major Wockhardt on Thursday reported widening of consolidated net loss to Rs 94.24 crore for the September quarter. The company had...
    Glenmark recalls over 2 lakh cartons of product in US

    Glenmark recalls over 2 lakh cartons of product in US

    Medical Dialogues Bureau11 Nov 2019 1:11 PM IST
    NEW DELHI: Drug maker Glenmark Pharmaceuticals is recalling close to 2.17 lakh cartons of Estradiol Vaginal inserts in the US market due to faulty...
    Delhi Pharmaceutical Sciences and Research University collaborates with China Pharma University for free research

    Delhi Pharmaceutical Sciences and Research University collaborates with China Pharma University for free research

    Medical Dialogues Bureau10 Nov 2019 4:52 PM IST
    This MoU will enable free research collaboration with China Pharmaceutical University(CPU). It is also planned to have some unique postgraduate level...
    Medical Representatives to now work 8 hours a day, get proper overtime: TN Govt Order

    Medical Representatives to now work 8 hours a day, get proper overtime: TN Govt Order

    Farhat Nasim8 Nov 2019 6:00 PM IST
    The notification also mentioned about the additional remuneration that the MRs and sales promotion employees would be entitled to in case of overtime,...
    PrevNext

    Popular Stories

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    Coronavirus Impact: Indian Pharma Exports to miss 22 Billion target, says Pharmexcil

    Coronavirus Impact: Indian Pharma Exports to miss 22 Billion target, says Pharmexcil

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok